William Wexler - Feb 7, 2025 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role
Director
Signature
/s/ William Wexler
Stock symbol
ERNA
Transactions as of
Feb 7, 2025
Transactions value $
$0
Form type
4
Date filed
2/10/2025, 07:00 PM
Previous filing
Nov 17, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Stock Option (right to buy) Award $0 +125K $0.00 125K Feb 7, 2025 Common Stock 125K $0.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.